Orikine Bio Alternatives & Competitors
12 companies similar to Orikine Bio — Orikine Bio is a pioneering biotech company dedicated to advancing the field of...
Companies similar to Orikine Bio
Alumis
Transforming the lives of patients living with immune-mediated diseases using a precision...
South San Francisco, Unit...
Eugit Therapeutics
Tissue targeting of therapies
San Carlos, United States
Immusoft
Cell therapy company dedicated to improving the lives of patients with rare diseases
Seattle, United States
Tridek-One
We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseas...
Paris, France
Rival Readout
Competing with Orikine Bio? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
SonoThera
SonoThera is developing ultrasound-mediated nonviral genetic therapies.
South San Francisco, Unit...
Mestag Therapeutics
New therapies for inflammatory disease and cancer by targeting fibroblast immunology
London, United Kingdom
Granza Bio
Reprogramming Immunity for Target-Specific Medicines
Generate:Biomedicines
Pioneering generative biology to create breakthrough therapeutics.
Somerville, United States
Solu Therapeutics
Solu Therapeutics is a next-generation therapeutics focused company working to eliminate c...
Boston, United States
Simcha Therapeutics
Overcoming biological challenges in clinically translatable pathways.
New Haven, United States
Anavo Therapeutics BV
UNLOCKING THE PHOSPHATASE TARGET CLASS
Leiden, The Netherlands
About Orikine Bio
Orikine Bio is a promising entrant in the Biotechnology sector, founded in 2022 and headquartered in Spain. The company emphasizes advancements in engineered cytokines, which are instrumental in treating immune-mediated diseases. With a mission to revolutionize medical therapies, Orikine Bio's approach aims to deliver...
Cytokine Engineering Platform, Therapeutic Development, Scientific Research
Healthcare Professionals, Biopharmaceutical Companies, Research Institutions
Engineered Cytokines, Immune-mediated Diseases, Transformative Therapies, Drug Development, Innovative Treatments, Cytokine Engineering, Biopharmaceuticals, Immune System Modulation, Personalized Medicine, Disease Modification, Therapeutic Innovation
B2B, B2D, Platform
Licensing, Product Sales, Service Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Orikine Bio: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Orikine Bio on 19 Mar 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 21 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
